English | 简体中文 | 繁體中文 | 한국어
 Japanese Press Releases
トヨタ、2025年上半期 販売・生産・輸出実績を発表
Jul 30, 2025 13:30 HKT
Naoris Protocol Announces Upcoming TGE for $NAORIS
Jul 29, 2025 23:59 HKT
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 05:00 HKT
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 21:00 HKT
KKR、トプコンに対する公開買付けを開始
Jul 28, 2025 19:30 HKT
From Hong Kong Airport to Hengqin: Chimelong Ferry Sets Sail for a Worry-Free Journey
Jul 28, 2025 14:30 HKT
Honda、軽乗用EV「N-ONE e:」をホームページで先行公開
Jul 28, 2025 11:30 HKT
maxWin Receives Honesty Award 2025, Setting New Standards for Integrity in Online Gaming
Jul 25, 2025 20:00 HKT
International Land Alliance Announces Tiny Home Offerings at Cabo Oasis Development
Jul 24, 2025 23:04 HKT
クオンタムソリューションズ、戦略的ビットコイン準備資産構築を発表
Jul 23, 2025 20:25 HKT
陸上養殖分野の発展に向けた取り組みとして、ShrimpTech JIRCASとIMTエンジニアリング、協業に向けた意向を表明
Jul 22, 2025 09:00 HKT
sureWin Wins Prestigious Honesty Award 2025 - A Testament to Trust in Online Gaming
Jul 21, 2025 17:30 HKT
S.BIOMEDICS Cell Therapy for Parkinson's Disease Shows Positive Data from Its Phase 1/2a Clinical Trial
Jul 21, 2025 17:00 HKT
Virturo Broker Launches Enhanced AI-Powered Trading Suite at London Investor Summit
Jul 18, 2025 19:00 HKT
アリマンタシォン・クシュタール、建設的な協議の欠如によりセブン&アイ買収提案の撤回を発表 取締役会宛てに書簡を送付
Jul 17, 2025 07:20 HKT
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today
Jul 16, 2025 16:00 HKT
エーザイ、抗アミロイドβ抗体レカネマブの創薬研究が「第 9 回バイオインダストリー大賞」を受賞
Jul 16, 2025 14:40 HKT
三菱重工、シンガポール「センカン・プンゴルLRT」向け新車両が営業運転を開始
Jul 16, 2025 14:40 HKT
maxWin Sports Makes It Debut in Motorsports with EBM-GIGA Racing Team
Jul 16, 2025 09:00 HKT
BlockBits Launches a Futures Trading Service, Offering Traders a Wide Range of Advanced Tools
Jul 14, 2025 20:00 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: